INO · Inovio Pharmaceuticals, Inc.
$1.09
+0.19 (+21.10%)
At close · Aug 14
View the 10-K filed Mar 12, 2026
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We do not currently have sufficient working capital to fund our planned operations for the next twelve months and substantial doubt exists as to our ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Customer concentration
— top customer 100% of revenue
One customer — 100% of revenue (the years ended December 31, 2025 and 2024)
“During the years ended December 31, 2025 and 2024, we derived 100% of our revenue from ApolloBio.”
Market Cap
$112.70M
Shares
103.40M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding INO
28 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Small Cap Growth Fund | — | 5,632,660 | $6,308,579 | 0.07% | Long | 2026-04-30 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 2,081,792 | $3,622,318 | 0.00% | Long | 2026-03-31 | |
| Fidelity Small Cap Growth K6 Fund | — | 2,822,120 | $3,160,774 | 0.07% | Long | 2026-04-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 738,660 | $1,285,268 | 0.00% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 348,001 | $455,881 | 0.00% | Long | 2026-05-31 | |
| Ultra-Small Company Fund | — | 173,000 | $301,020 | 0.35% | Long | 2026-03-31 | |
| iShares Micro-Cap ETF | — | 170,694 | $297,008 | 0.02% | Long | 2026-03-31 | |
| Fidelity Total Market Index Fund | — | 104,005 | $136,247 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | — | 96,119 | $125,916 | 0.00% | Long | 2026-05-31 | |
| Small Cap Core Fund | — | 47,318 | $82,333 | 0.02% | Long | 2026-03-31 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 42,017 | $73,110 | 0.00% | Long | 2026-03-31 | |
| VANGUARD BALANCED INDEX FUND | — | 38,739 | $67,406 | 0.00% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 45,041 | $59,004 | 0.00% | Long | 2026-05-31 | |
| Goldman Sachs Absolute Return Tracker Fund | — | 27,231 | $47,382 | 0.00% | Long | 2026-03-31 | |
| Amplify Treatments, Testing and Advancements ETF | AIEQ | 5,746 | $46,425 | 0.50% | Long | 2024-06-30 | |
| TIFF MULTI-ASSET FUND | — | 21,590 | $37,567 | 0.00% | Long | 2026-03-31 | |
| Defiance Nasdaq Junior Biotechnology ETF | ABUF | 4,810 | $34,440 | 0.48% | Long | 2021-09-30 | |
| 1290 VT Micro Cap Portfolio | — | 11,818 | $20,563 | 0.01% | Long | 2026-03-31 | |
| Direxion Fallen Knives ETF | AAPD | 7,186 | $14,228 | 0.60% | Long | 2022-07-31 | |
| iShares Evolved U.S. Innovative Healthcare ETF | AGRH | 5,064 | $10,027 | 0.03% | Long | 2022-07-31 | |
| ProShares UltraPro Nasdaq Biotechnology | ANEW | 2,319 | $9,925 | 0.05% | Long | 2020-02-29 | |
| Victory Extended Market Index Fund | — | 7,821 | $8,760 | 0.00% | Long | 2026-04-30 | |
| Small-Mid Cap Equity Fund | MSLC | 950 | $4,104 | 0.00% | Long | 2024-11-30 | |
| iShares Factors US Small Blend Style ETF | AAXJ | 400 | $3,708 | 0.05% | Long | 2021-06-30 | |
| Total Stock Market Index Trust | — | 1,257 | $2,187 | 0.00% | Long | 2026-03-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 1,008 | $1,754 | 0.00% | Long | 2026-03-31 | |
| Knights of Columbus U.S. ALL CAP INDEX FUND | — | 359 | $402 | 0.00% | Long | 2026-04-30 | |
| Guggenheim Active Allocation Fund | GUG | 205 | $269 | 0.00% | Long | 2026-05-29 |
Showing 1–28 of 28 positions
Key facts
CIK
1055726
CUSIP
45773H409
13F (30d)
103 filings
101 filers
Visit website
Investor relations